Costs and benefits of routine hemoglobin A1c screening prior to total joint arthroplasty: a cost-benefit analysis

Conclusions: Routine HbA1c screening in patients with DM prior to THA with referral of patients with elevated HbA1c for glycemic optimization may prevent PJI and reduce healthcare costs. In contrast, routine screening in patients with DM prior to TKA or in patients with no history of DM is not cost-saving. Level of Evidence: Economic Level IV.
Source: Current Orthopaedic Practice - Category: Orthopaedics Tags: Original Research Source Type: research